Brief: Protara Therapeutics Q3 EPS USD -0.5
12/11/2024 13:00
Nov 12 (Reuters) - Protara Therapeutics Q3 net income USD -11.219 million. * Q3 income from operations USD -12.33 million * Q3 operating expenses USD 12.33 million
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses